Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

It’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...

The CDC monitors RSV through the Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET), which comprises 161 counties and county-equivalents in 13 states. The network ...

HMPV belongs to the Paramyxoviridae family, a group of viruses that also includes the respiratory syncytial virus (RSV), according ... in terms of structure, replication mechanisms, and how ...

But there's a fourth "bug" the public should be aware of: respiratory syncytial virus. RSV causes cold-like symptoms and affects the breathing passages and lungs. Wastewater levels of RSV are ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...

With respiratory virus season in full swing in California, you may be feeling under the weather. Cases of the flu and respiratory syncytial virus are on the rise in California, the California ...

Host immune and proinflammatory responses to respiratory virus infections play key roles ... indicating a central role of viral replication in driving these responses. [45] Mixed infections ...

A 3D reconstruction of a mouse lung four days after infection with fluorescent Sendai virus reveals widespread virus presence (red) and active replication (green). A study by researchers at WashU ...